Vitamin D3 for Life

Live Enlightened

Article

Vitamin D Receptors, Muscle Protein Synthesis and Adaptation: Full Evidence Review

Previous related pageVitamin D in Older AdultsNext related pageVitamin D Receptors, Muscle Protein Synthesis and Adaptation: Study Summary
Study at a glance

How were vitamin D signals, muscle growth and exercise recovery studied?

This review combines cell and animal experiments with human studies of training and exercise recovery. Researchers examined vitamin D compounds and the vitamin D receptor, which allows cells to respond to vitamin D signals. Adding compounds to cells, greatly increasing receptor levels and giving supplements to people are different tests.

How did vitamin D signals affect muscle cells and animals?

Some vitamin D exposures changed the growth of developing muscle cells, but results depended on concentration and stage of development. Greatly increasing the receptor in rat muscle produced larger fibres and increased the making of muscle proteins. It did not clearly improve how much glucose entered the cells. Exercise-related receptor changes in aged mice could involve supporting cells rather than the muscle fibres themselves.

Did human studies show better muscle growth or exercise recovery?

Among 37 adults doing muscle-strengthening resistance training, changes in receptor gene activity were linked with gains in muscle mass. They were not given a vitamin D treatment, so the link does not show that supplements caused the gains. In a separate trial of 28 men, vitamin D gave a better result on one measure of how muscle force recovered during the first day after exercise. Overall force and power patterns, later recovery and soreness did not clearly improve.

Do these findings establish better training results or muscle repair?

Larger fibres and increased protein production do not automatically mean greater strength or repaired injury. The recovery trial was small, changed its analysis approach and included men with mixed starting vitamin D levels. Four supplemented participants had calcium above the laboratory range after exercise, but the cause was uncertain. These studies do not establish a supplement dose, improved training results or treatment for muscle injury.

Read the full article below ↓

Vitamin D receptor experiments connect muscle growth with protein synthesis, cellular signalling and the cells involved in remodelling. The findings include a preliminary human recovery signal after damaging exercise, alongside cellular and animal experiments. Their different interventions and outcomes do not establish a general supplement benefit for training or injury treatment. The companion appraisal is Vitamin D Receptors, Muscle Protein Synthesis and Adaptation: Study Summary.

Different experiments, different questions

This review compares a mouse muscle-cell experiment by van der Meijden and colleagues, a rat receptor-overexpression experiment with a human training analysis by Bass and colleagues, and a later study of acute exercise in aged mice, together with Barker’s human exercise-recovery trial. Their exposures differ fundamentally. Adding vitamin D metabolites to a culture changes the chemical environment. Increasing receptor expression changes the capacity of a tissue to respond and may produce effects beyond ordinary physiological regulation. Exercising an animal recruits many signalling systems at once.

The shared question is how vitamin D-related signalling intersects with muscle metabolism and adaptation. The studies cannot be pooled as if they measured the same intervention. They are most informative when their differences are retained: cell growth versus fibre growth, biochemical synthesis versus performance, and receptor localisation versus proof of receptor-mediated causation. Vitamin D and Skeletal Muscle Function provides the tissue context for these distinctions.

What cultured muscle cells revealed

Van der Meijden and colleagues studied C2C12 mouse cells during proliferation and differentiation. In their higher-concentration proliferation experiments, 1,000 nM 25-hydroxyvitamin D and 100 nM calcitriol reduced the XTT assay signal at day four by approximately 30.1% and 27.6%, respectively. XTT reflects a cellular metabolic signal used as an indicator of viable cell abundance. It is not a direct count of completed cell divisions and should not be described as proving a specific cell-cycle mechanism.

During differentiation, the response was not a simple extension of reduced proliferation. After three days, 400 nM 25-hydroxyvitamin D was associated with approximately 19% greater myotube diameter, with P < 0.05 reported in the results. The high calcitriol condition did not produce the same diameter response, and myotube number did not clearly change. This separates growth of existing myotubes from formation of more myotubes. It also shows why a response to the precursor cannot automatically be assigned to the active metabolite.

The cells showed changes in VDR and CYP24A1 expression, consistent with responsiveness to the vitamin D system. The investigators did not find corresponding changes in every developmental marker or in their measured Akt and S6 signalling outcomes. A receptor-responsive transcriptional result therefore did not establish uniform activation of the proposed growth pathway. In the lower-concentration conditions, the reported hypertrophy response was absent. Concentration, timing and the stage of differentiation all restrict the interpretation.

Local metabolism is not the same as net hormone accumulation

The cell experiment also examined metabolism of the supplied compounds. It detected production of the 24-hydroxylated metabolite after precursor exposure but did not demonstrate a clear net increase in calcitriol in the culture medium. That result needs to be read alongside assay sensitivity, cross-reactivity and simultaneous metabolite formation and removal. It cannot prove that no active hormone was ever formed inside any cell.

Vitamin D Activation is relevant because conversion, degradation and local availability can differ from the concentration added to a dish. The experiment does not measure the concentration at every receptor or reproduce protein binding and endocrine regulation in a person. Its high-concentration findings are mechanistic observations, not a way to calculate an oral supplement regimen. Nor does a larger myotube demonstrate better force production or recovery after an injury.

Increasing the receptor in rat muscle

Bass and colleagues used electrotransfer to increase VDR expression in the tibialis anterior of young male Wistar rats. The opposite leg received the control construct, allowing a paired comparison within an animal. The animals ate vitamin D-fortified maintenance chow; this was not a deficiency-correction experiment. Measurements were made ten days after the intervention, with overnight fasting before collection to examine the resting state rather than an immediate feeding response.

Receptor expression was increased far beyond an ordinary physiological fluctuation, with a very large increase in VDR protein and an even larger increase in Vdr messenger RNA. The Results text reports a 1,232% protein increase, whereas Figure 1 labels it 1,132%; the discrepancy is left unresolved. Both presentations indicate extensive experimental overexpression. This matters when interpreting Vitamin D Receptors: the intervention tests unusually high receptor abundance, not a receptor change demonstrated after dietary supplementation.

The paired design reduces variation arising from differences between animals. Both limbs nevertheless share the same organism, and the manipulation is an experimental procedure in a particular muscle. A ten-day result in a predominantly fast-fibre muscle cannot establish the long-term effects across all muscles, ages or sexes. The study also does not independently vary vitamin D availability, so independence from a vitamin D intervention must not be mistaken for proof that ligand availability is irrelevant.

Fibre growth and directly measured protein synthesis

Mean fibre cross-sectional area was approximately 1,904 versus 1,627 square micrometres in receptor-overexpressing and control muscles. The type IIa comparison also showed larger fibres. Protein and RNA content increased, while total DNA content did not show a corresponding increase. Histology and tissue chemistry therefore supported a growth response, rather than reliance on a single signalling marker.

The authors used deuterated water to measure incorporation into newly synthesised muscle proteins. The reported mixed-muscle synthesis rate was approximately 17.3% per day in the overexpression condition versus 10.2% per day in controls. Increases were also observed across several protein fractions, including myofibrillar and collagen fractions. This directly measured synthesis is a stronger connection to Vitamin D and Protein Metabolism than inferring synthesis solely from phosphorylation of a signalling protein.

Synthesis is nevertheless only one component of protein balance. Markers of proteasomal degradation also increased, and the study did not establish that protein breakdown was uniformly suppressed. Tissue growth can involve faster turnover and restructuring rather than simply turning breakdown off. Moreover, a fractional synthesis rate is not the percentage increase in whole-muscle mass and should not be presented that way. The measurements describe the replacement or production of proteins over the tracer interval.

The overexpression experiment found increases in measured components of Akt: mTOR signalling and greater co-localisation of mTOR with the lysosomal marker LAMP2. These observations fit a growth-permissive signalling environment. They do not by themselves prove that every step in this pathway was necessary for the VDR effect. Demonstrating necessity would require an appropriately controlled blockade or rescue within the same experimental question.

RNA sequencing identified changes in extracellular-matrix and integrin gene sets, together with changes in individual cell-cycle genes. The named cell-cycle gene sets did not meet the reported adjusted-significance threshold. Some mTOR-related gene sets changed in the opposite direction from the measured protein-synthesis response. A snapshot of relative messenger RNA abundance, total RNA content and measured protein synthesis describes different biological quantities. Vitamin D and Gene Expression helps explain why their directions need not match perfectly.

The distinction also prevents an overly broad metabolic claim. Muscle glucose uptake and glycogen content were not clearly improved by receptor overexpression under the conditions tested. The growth findings therefore cannot be converted into evidence of improved insulin sensitivity or glucose disposal. The experiment supports a particular anabolic and remodelling phenotype while leaving other metabolic outcomes unchanged or unresolved.

Satellite cells and the limits of a repair claim

Satellite cells are relevant to muscle renewal, but their measured abundance is not equivalent to successful regeneration. In the Bass study, the overall difference in PAX7-positive satellite-cell content was a statistical trend, with P = 0.07. A fibre-type-specific comparison showed a clearer difference. This distinction matters: the result should not be summarised as a uniform, statistically established increase across all fibres.

Expression of Pax7 and a proliferation-associated marker increased, while some differentiation markers did not. The authors noted that the short observation interval did not establish that satellite-cell fusion accounted for the fibre growth. There was no injury followed by a demonstration of restored force. Vitamin D and Tissue Repair therefore provides a relevant physiological connection, but the present data establish processes associated with remodelling rather than a completed clinical repair benefit.

A later acute-exercise experiment adds a useful localisation caution. Thirty-three aged male mice were assigned to sedentary or post-exercise sampling groups, with tissues collected one, four or twenty-four hours after a short exercise bout. VDR messenger RNA increased at four hours, and protein findings persisted later. Microscopy placed VDR signal with satellite-cell and macrophage markers near muscle fibres. Consequently, a whole-muscle increase need not represent increased receptor abundance in the contractile fibres themselves.

The exercise study did not manipulate VDR to test whether it was necessary for recovery. Its authors also acknowledged very low receptor abundance near the detection limits of some assays. The images and timing suggest involvement of supporting cells, but they do not establish whether more cells were recruited, existing cells expressed more receptor, or both occurred. Nor do they show that vitamin D caused the exercise response. These are important competing explanations when interpreting tissue-level measurements.

What the human training analysis contributes

Bass and colleagues also analysed paired samples from 37 adults who completed twenty weeks of resistance training. Changes in muscle VDR gene expression were associated with lean-mass gains. The participants did not receive a vitamin D intervention, and the analysis was correlational. Training, baseline characteristics and other responses to exercise could influence both receptor expression and muscle growth.

The association did not extend cleanly to strength gains, and changes in circulating vitamin D did not track lean-mass gains in the same way. This reinforces the distinction between tissue expression, a blood biomarker and function. Vitamin D and Muscle Function includes force and physical performance, which cannot be inferred solely from increased lean mass or fibre size. The complementary Muscle VDR Deletion, Fibre Structure and Strength in Mice: Full Study examines a different perturbation and a measured performance phenotype.

Direct human recovery after exercise

Barker and colleagues assigned twenty-eight modestly active men to 4,000 IU/day vitamin D3 or placebo for thirty-five days. On day twenty-eight, one leg performed repeated eccentric: concentric contractions. The mean starting 25-hydroxyvitamin D concentration was about 31 ng/mL, with both lower-status and sufficient participants under the authors’ categories. This was not a trial restricted to deficient men. The research regimen describes the experiment and is not a treatment recommendation.

The overall force and power trajectories did not differ significantly between groups. A narrower comparison of recovery from immediately after exercise to twenty-four hours favoured vitamin D for peak isometric force by about eight percentage points. The corresponding power comparison was not significant (P = 0.10), and later recovery intervals and muscle soreness did not show a treatment advantage. The positive finding therefore concerns one early recovery contrast, not a demonstrated improvement across the entire recovery period.

That contrast requires additional caution. The investigators had intended to normalise the exercised leg against the other leg, but the other leg also lost force after exercise. They changed the approach to percentage recovery between time points. The vitamin D group also tended to have a larger immediate deficit, leaving more room for recovery, and exercise completion varied between participants. The methods name a signed-rank test for non-normal recovery comparisons, without clearly reconciling that paired-test terminology with the independent treatment groups. These features limit the robustness of the isolated positive result.

Selected alanine and aspartate aminotransferase measurements were lower after supplementation, but these circulating enzymes are not specific measures of muscle repair. No muscle biopsy established microscopic regeneration, and the experiment did not distinguish recovery from fatigue from repair of damaged tissue. Mean calcium and parathyroid-hormone comparisons were not significantly different between treatment groups; nevertheless, four supplemented participants had calcium above the laboratory reference range after exercise. The timing does not establish whether exercise, supplementation or their combination accounted for these individual observations.

This trial supplies a direct functional test alongside the cellular and animal work. Its small male sample, mixed starting vitamin D status, changed recovery analysis and discordant endpoints make the positive finding preliminary. It does not demonstrate that a VDR-dependent pathway mediated recovery, and it cannot establish improved rehabilitation after clinical injury or enhanced training adaptation. The molecular experiments and the human result remain complementary evidence with an unproven causal connection.

Barker and colleagues disclosed that USANA supplied the study supplements and that two coauthors were employees of the company. That context is relevant when assessing the small exercise-recovery study alongside its analysis choices and uncertainty; it does not by itself determine whether the measured result is valid.

Conclusion

Taken together, the experiments support a role for vitamin D-related signalling in the cellular environment of muscle growth and remodelling. They do not establish a supplement dose, a training prescription or a treatment for muscle injury. The next mechanistic questions concern physiological receptor regulation, the identity of responding cells, and whether specific signalling changes cause improved function. The small recovery trial adds a preliminary human signal; larger, independently replicated trials would be needed to establish its reliability and wider applicability.

Sources and publication details

Effects of 1,25(OH)2D3 and 25(OH)D3 on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy. van der Meijden K. and colleagues. Journal of Cellular Physiology. 2016;231(11):2517-2528. DOI: 10.1002/jcp.25388. PMID: 27018098.

Overexpression of the vitamin D receptor (VDR) induces skeletal muscle hypertrophy. Bass Joseph J. and colleagues. Molecular Metabolism. 2020;42:101059. DOI: 10.1016/j.molmet.2020.101059. PMID: 32771696.

High-Intensity Interval Exercise Drives Vitamin D Receptor Expression in Skeletal Muscle via Recruitment of Non-Parenchymal Cells, Not Upregulation in Muscle Fibers. Seldeen KL and colleagues. Nutrients. 2025;17(23):3733. DOI: 10.3390/nu17233733. PMID: 41374023.

Supplemental vitamin D enhances the recovery in peak isometric force shortly after intense exercise. Barker T and colleagues. Nutrition & Metabolism. 2013;10:69. DOI: 10.1186/1743-7075-10-69. PMID: 24313936.

Related reading

Original sources

Source

High-Intensity Interval Exercise Drives Vitamin D Receptor Expression in Skeletal Muscle via Recruitment of Non-Parenchymal Cells, Not Upregulation in Muscle Fibers

Published in Seldeen KL and colleagues. Nutrients (2025).

Publication details

High-Intensity Interval Exercise Drives Vitamin D Receptor Expression in Skeletal Muscle via Recruitment of Non-Parenchymal Cells, Not Upregulation in Muscle Fibers. Seldeen KL and colleagues. Nutrients. 2025;17(23):3733. DOI: 10.3390/nu17233733. PMID: 41374023.

Read more →
Source

Supplemental vitamin D enhances the recovery in peak isometric force shortly after intense exercise

Serum 25-hydroxyvitamin D (25(OH)D) concentrations associate with skeletal muscle weakness (i.e., deficit in skeletal muscle strength) after muscular injury or damage.

Publication details

Supplemental vitamin D enhances the recovery in peak isometric force shortly after intense exercise. Barker T and colleagues. Nutrition & Metabolism. 2013;10:69. DOI: 10.1186/1743-7075-10-69. PMID: 24313936.

Read more →